Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 89

1.

Fast, Flexible Closed-Loop Feedback: Tracking Movement in "Real-Millisecond-Time".

Sehara K, Bahr V, Mitchinson B, Pearson MJ, Larkum ME, Sachdev RNS.

eNeuro. 2019 Nov 1;6(6). pii: ENEURO.0147-19.2019. doi: 10.1523/ENEURO.0147-19.2019. Print 2019 Nov/Dec.

2.

Neuronal Responses to Conspecifics in the Ventral CA1.

Rao RP, von Heimendahl M, Bahr V, Brecht M.

Cell Rep. 2019 Jun 18;27(12):3460-3472.e3. doi: 10.1016/j.celrep.2019.05.081.

3.

Can complementary medicine enhance doctor-patient communication skills? Insights from an international medical student project.

Ortiz M, Teut M, Ben-Arye E, Reshef A, Kaffman M, Arnon Z, Stöckigt B, Bähr V, Meoded-Danon L, Brinkhaus B, Schiff E.

Complement Ther Med. 2018 Dec;41:283-286. doi: 10.1016/j.ctim.2018.10.012. Epub 2018 Oct 18.

PMID:
30477854
4.

Acquired von Willebrand syndrome in respiratory extracorporeal life support: a systematic review of the literature.

Malfertheiner MV, Pimenta LP, Bahr VV, Millar JE, Obonyo NG, Suen JY, Pellegrino V, Fraser JF.

Crit Care Resusc. 2017 Oct;19(Suppl 1):45-52.

PMID:
29084501
5.

Glucagon Decreases IGF-1 Bioactivity in Humans, Independently of Insulin, by Modulating Its Binding Proteins.

Sarem Z, Bumke-Vogt C, Mahmoud AM, Assefa B, Weickert MO, Adamidou A, Bähr V, Frystyk J, Möhlig M, Spranger J, Lieske S, Birkenfeld AL, Pfeiffer AFH, Arafat AM.

J Clin Endocrinol Metab. 2017 Sep 1;102(9):3480-3490. doi: 10.1210/jc.2017-00558.

6.

Effect of smoking cessation counseling within a randomised study on early detection of lung cancer in Germany.

Bade M, Bähr V, Brandt U, Eigentopf A, Brüchert T, Gross ML, Motsch E, Becker N.

J Cancer Res Clin Oncol. 2016 May;142(5):959-68. doi: 10.1007/s00432-015-2105-0. Epub 2016 Jan 27.

PMID:
26814889
7.

Overwhelming Postsplenectomy Infection: A Prospective Multicenter Cohort Study.

Theilacker C, Ludewig K, Serr A, Schimpf J, Held J, Bögelein M, Bahr V, Rusch S, Pohl A, Kogelmann K, Frieseke S, Bogdanski R, Brunkhorst FM, Kern WV.

Clin Infect Dis. 2016 Apr 1;62(7):871-878. doi: 10.1093/cid/civ1195. Epub 2015 Dec 23.

PMID:
26703862
8.

The flavones apigenin and luteolin induce FOXO1 translocation but inhibit gluconeogenic and lipogenic gene expression in human cells.

Bumke-Vogt C, Osterhoff MA, Borchert A, Guzman-Perez V, Sarem Z, Birkenfeld AL, Bähr V, Pfeiffer AF.

PLoS One. 2014 Aug 19;9(8):e104321. doi: 10.1371/journal.pone.0104321. eCollection 2014.

9.

Arginine vasopressin-dependent and AVP-independent mechanisms of renal fluid absorption during thirsting despite glucocorticoid-mediated vasopressin suppression.

Ufer F, Diederich S, Pedersen EB, Spranger J, Pfeiffer AF, Bähr V, Mai K.

Clin Endocrinol (Oxf). 2013 Mar;78(3):431-7. doi: 10.1111/cen.12006.

PMID:
22882308
10.

Novel inactivating mutations of the calcium-sensing receptor: the calcimimetic NPS R-568 improves signal transduction of mutant receptors.

Rus R, Haag C, Bumke-Vogt C, Bähr V, Mayr B, Möhlig M, Schulze E, Frank-Raue K, Raue F, Schöfl C.

J Clin Endocrinol Metab. 2008 Dec;93(12):4797-803. doi: 10.1210/jc.2008-1076. Epub 2008 Sep 16.

PMID:
18796518
11.

Is there a need for vitamin C supplementation of the normal diet? Effects of in vivo ascorbate depletion on adrenal function.

Bähr V, Pfeiffer AF, Oelkers W.

Am J Clin Nutr. 2008 Jan;87(1):191; author reply 191-2. doi: 10.1093/ajcn/87.1.191. No abstract available.

PMID:
18175756
12.

Cell-type specific regulation of the human 11beta-hydroxysteroid dehydrogenase type 1 promoter.

Andres J, Mai K, Möhlig M, Weickert MO, Bumke-Vogt C, Diederich S, Pfeiffer AF, Bähr V, Spranger J.

Arch Physiol Biochem. 2007 Jun;113(3):110-5.

PMID:
17922306
13.

Effect of immunosuppressive and other drugs on the cortisol-cortisone shuttle in human kidney and liver.

Quinkler M, Jussli J, Bähr V, Pfeiffer AF, Lepenies J, Diederich S.

Horm Metab Res. 2007 Aug;39(8):555-9.

PMID:
17712719
14.

The simultaneous measurement of plasma-aldosterone- and -renin-concentration allows rapid classification of all disorders of the renin-aldosterone system.

Diederich S, Mai K, Bähr V, Helffrich S, Pfeiffer A, Perschel FH.

Exp Clin Endocrinol Diabetes. 2007 Jul;115(7):433-8.

PMID:
17647140
15.

Rosiglitazone decreases 11beta-hydroxysteroid dehydrogenase type 1 in subcutaneous adipose tissue.

Mai K, Andres J, Bobbert T, Maser-Gluth C, Möhlig M, Bähr V, Pfeiffer AF, Spranger J, Diederich S.

Clin Endocrinol (Oxf). 2007 Sep;67(3):419-25. Epub 2007 Jun 6.

PMID:
17555498
16.

Effect of exogenous glucocorticoid on osmotically stimulated antidiuretic hormone secretion and on water reabsorption in man.

Bähr V, Franzen N, Oelkers W, Pfeiffer AF, Diederich S.

Eur J Endocrinol. 2006 Dec;155(6):845-8.

PMID:
17132754
17.

Vasopressin excess and hyponatremia: hydrocortisone treatment should be considered.

Bähr V, Franzen NF, Pfeiffer AF, Diederich S, Oelkers W.

Am J Kidney Dis. 2006 Aug;48(2):339; author reply 339-40. No abstract available.

PMID:
16860205
18.

No effect of free fatty acids on adrenocorticotropin and cortisol secretion in healthy young men.

Mai K, Bobbert T, Kullmann V, Andres J, Bähr V, Maser-Gluth C, Rochlitz H, Spranger J, Diederich S, Pfeiffer AF.

Metabolism. 2006 Aug;55(8):1022-8.

PMID:
16839836
19.

Metabolism of synthetic steroids by the human placenta.

Bähr V, Oelkers W, Pfeiffer AF, Diederich S.

Placenta. 2007 May-Jun;28(5-6):588-9. Epub 2006 Jul 3. No abstract available.

PMID:
16820201
20.

Free fatty acids increase androgen precursors in vivo.

Mai K, Bobbert T, Kullmann V, Andres J, Rochlitz H, Osterhoff M, Weickert MO, Bähr V, Möhlig M, Pfeiffer AF, Diederich S, Spranger J.

J Clin Endocrinol Metab. 2006 Apr;91(4):1501-7. Epub 2006 Jan 24.

PMID:
16434463
21.

In vivo activity of 11beta-hydroxysteroid dehydrogenase type 1 and free fatty acid-induced insulin resistance.

Mai K, Kullmann V, Bobbert T, Maser-Gluth C, Möhlig M, Bähr V, Pfeiffer AF, Spranger J, Diederich S.

Clin Endocrinol (Oxf). 2005 Oct;63(4):442-9.

PMID:
16181237
22.

Glucagon inhibits ghrelin secretion in humans.

Arafat MA, Otto B, Rochlitz H, Tschöp M, Bähr V, Möhlig M, Diederich S, Spranger J, Pfeiffer AF.

Eur J Endocrinol. 2005 Sep;153(3):397-402.

PMID:
16131602
24.

Transactivation via the human glucocorticoid and mineralocorticoid receptor by therapeutically used steroids in CV-1 cells: a comparison of their glucocorticoid and mineralocorticoid properties.

Grossmann C, Scholz T, Rochel M, Bumke-Vogt C, Oelkers W, Pfeiffer AF, Diederich S, Bahr V.

Eur J Endocrinol. 2004 Sep;151(3):397-406.

PMID:
15362971
25.

Function of human mineralocorticoid receptor splice variant.

Bahr V, Bumke-Vogt C, Gotze J, Pfeiffer AF, Diederich S.

Eur J Endocrinol. 2004 Aug;151(2):295. No abstract available.

PMID:
15296487
26.

Pharmacodynamics and pharmacokinetics of synthetic mineralocorticoids and glucocorticoids: receptor transactivation and prereceptor metabolism by 11beta-hydroxysteroid-dehydrogenases.

Diederich S, Scholz T, Eigendorff E, Bumke-Vogt Ch, Quinkler M, Exner P, Pfeiffer AF, Oelkers W, Bähr V.

Horm Metab Res. 2004 Jun;36(6):423-9.

PMID:
15241735
27.

The role of progesterone metabolism and androgen synthesis in renal blood pressure regulation.

Quinkler M, Diederich S, Bähr V, Oelkers W.

Horm Metab Res. 2004 Jun;36(6):381-6. Review.

PMID:
15241728
28.

The human kidney is a progesterone-metabolizing and androgen-producing organ.

Quinkler M, Bumke-Vogt C, Meyer B, Bähr V, Oelkers W, Diederich S.

J Clin Endocrinol Metab. 2003 Jun;88(6):2803-9.

PMID:
12788891
29.

Severe hyponatremia due to hypopituitarism with adrenal insufficiency: report on 28 cases.

Diederich S, Franzen NF, Bähr V, Oelkers W.

Eur J Endocrinol. 2003 Jun;148(6):609-17.

PMID:
12773132
30.

[Monogenic hypertension].

Bähr V, Oelkers W, Diederich S.

Med Klin (Munich). 2003 Apr 15;98(4):208-17. Review. German.

PMID:
12715144
31.

Enhanced 11beta-hydroxysteroid dehydrogenase type 1 activity in stress adaptation in the guinea pig.

Quinkler M, Troeger H, Eigendorff E, Maser-Gluth C, Stiglic A, Oelkers W, Bähr V, Diederich S.

J Endocrinol. 2003 Feb;176(2):185-92.

PMID:
12553867
32.

11beta-hydroxysteroid dehydrogenase types 1 and 2: an important pharmacokinetic determinant for the activity of synthetic mineralo- and glucocorticoids.

Diederich S, Eigendorff E, Burkhardt P, Quinkler M, Bumke-Vogt C, Rochel M, Seidelmann D, Esperling P, Oelkers W, Bähr V.

J Clin Endocrinol Metab. 2002 Dec;87(12):5695-701.

PMID:
12466373
33.

Expression of the progesterone receptor and progesterone- metabolising enzymes in the female and male human kidney.

Bumke-Vogt C, Bähr V, Diederich S, Herrmann SM, Anagnostopoulos I, Oelkers W, Quinkler M.

J Endocrinol. 2002 Nov;175(2):349-64.

PMID:
12429033
34.

The metabolic syndrome X and peripheral cortisol synthesis.

Bähr V, Pfeiffer AF, Diederich S.

Exp Clin Endocrinol Diabetes. 2002 Oct;110(7):313-8. Review.

PMID:
12397528
35.

Agonistic and antagonistic properties of progesterone metabolites at the human mineralocorticoid receptor.

Quinkler M, Meyer B, Bumke-Vogt C, Grossmann C, Gruber U, Oelkers W, Diederich S, Bahr V.

Eur J Endocrinol. 2002 Jun;146(6):789-99.

PMID:
12039699
36.

Differential diagnosis of polyuric/polydipsic syndromes with the aid of urinary vasopressin measurement in adults.

Diederich S, Eckmanns T, Exner P, Al-Saadi N, Bähr V, Oelkers W.

Clin Endocrinol (Oxf). 2001 May;54(5):665-71. Erratum in: Clin Endocrinol (Oxf) 2001 Oct;55(4):563.

PMID:
11380498
37.

Therapeutic strategies in adrenal insufficiency.

Oelkers W, Diederich S, Bähr V.

Ann Endocrinol (Paris). 2001 Apr;62(2):212-6. Review.

PMID:
11353897
38.

11Beta-hydroxysteroid-dehydrogenase isoforms: tissue distribution and implications for clinical medicine.

Diederich S, Quinkler M, Burkhardt P, Grossmann C, Bähr V, Oelkers W.

Eur J Clin Invest. 2000 Dec;30 Suppl 3:21-7. Review.

PMID:
11281363
39.

Enzyme-mediated protection of the mineralocorticoid receptor against progesterone in the human kidney.

Quinkler M, Johanssen S, Bumke-Vogt C, Oelkers W, Bähr V, Diederich S.

Mol Cell Endocrinol. 2001 Jan 22;171(1-2):21-4.

PMID:
11165007
40.

Primary hyperaldosteronism without suppressed renin due to secondary hypertensive kidney damage.

Oelkers W, Diederich S, Bähr V.

J Clin Endocrinol Metab. 2000 Sep;85(9):3266-70.

PMID:
10999820
41.

Dose-response relationship between plasma ACTH and serum cortisol in the insulin-hypoglycaemia test in 25 healthy subjects and 109 patients with pituitary disease.

Tuchelt H, Dekker K, Bähr V, Oelkers W.

Clin Endocrinol (Oxf). 2000 Sep;53(3):301-7. Erratum in: Clin Endocrinol (Oxf) 2001 Jan;54(1):135.

PMID:
10971446
42.

In the search for specific inhibitors of human 11beta-hydroxysteroid-dehydrogenases (11beta-HSDs): chenodeoxycholic acid selectively inhibits 11beta-HSD-I.

Diederich S, Grossmann C, Hanke B, Quinkler M, Herrmann M, Bähr V, Oelkers W.

Eur J Endocrinol. 2000 Feb;142(2):200-7.

PMID:
10664531
43.

Progesterone metabolism in the human kidney and inhibition of 11beta-hydroxysteroid dehydrogenase type 2 by progesterone and its metabolites.

Quinkler M, Johanssen S, Grossmann C, Bähr V, Müller M, Oelkers W, Diederich S.

J Clin Endocrinol Metab. 1999 Nov;84(11):4165-71.

PMID:
10566667
44.

[11 beta-hydroxysteroid dehydrogenases: key enzymes in the action of mineralocorticoids and glucocorticoids].

Diederich S, Quinkler M, Hanke B, Bähr V, Oelkers W.

Dtsch Med Wochenschr. 1999 Jan 22;124(3):51-5. Review. German. No abstract available.

PMID:
9987486
45.

Torsemide inhibits aldosterone secretion in vitro.

Goodfriend TL, Ball DL, Oelkers W, Bähr V.

Life Sci. 1998;63(3):PL45-50.

PMID:
9698054
46.

Metabolism of synthetic corticosteroids by 11 beta-hydroxysteroid-dehydrogenases in man.

Diederich S, Hanke B, Burkhardt P, Müller M, Schöneshöfer M, Bähr V, Oelkers W.

Steroids. 1998 May-Jun;63(5-6):271-7.

PMID:
9618784
47.

Comparison of low and high dose corticotropin stimulation tests in patients with pituitary disease.

Mayenknecht J, Diederich S, Bähr V, Plöckinger U, Oelkers W.

J Clin Endocrinol Metab. 1998 May;83(5):1558-62.

PMID:
9589655
48.

Evidence for isoforms of 11 beta-hydroxysteroid dehydrogenase in the liver and kidney of the guinea pig.

Quinkler M, Kosmale B, Bähr V, Oelkers W, Diederich S.

J Endocrinol. 1997 May;153(2):291-8.

PMID:
9166119
49.

Metabolism of dexamethasone in the human kidney: nicotinamide adenine dinucleotide-dependent 11beta-reduction.

Diederich S, Hanke B, Oelkers W, Bähr V.

J Clin Endocrinol Metab. 1997 May;82(5):1598-602.

PMID:
9141556
50.

The metabolism of 9 alpha-fluorinated steroids in the human kidney.

Diederich S, Hanke B, Bähr V, Oelkers W.

Endocr Res. 1996 Nov;22(4):803-10.

PMID:
8969943

Supplemental Content

Support Center